A study of 2,000 adults has found eight in 10 people with regular pain issues such as back pain, arthritis, and fibromyalgia are struggling with day-to-day living. The study, produced by medical cannabis provider Curaleaf Clinic found that 40 per cent of people living with regular pain issues can’t remember the last full night’s sleep
Moderate cannabis use does not cause problems with psychological health, study finds
A study involving adult twins has found little evidence that ‘moderate’ cannabis causes negative effects on mental health. The study, published in the Journal of Psychopathology and Clinical Science, analysed a sample of 4,078 American adult twins over 30 years to investigate the effects of lifetime cannabis use. Researchers assessed twins who lived together as children
Cannabis legalisation leads to a reduction in beer sales, data shows
A study of data published in the journal Drug and Alcohol Dependence has found that cannabis legalisation in Canada has led to a reduction in retail sales of beer. Researchers examined alcohol retail data in Canada from 2012 to 2020 to understand the changes in the volume of beer and spirits sold after the legalisation
Cannabis use linked to greater chance of avoiding early symptoms of Alzheimer’s disease
People who consume cannabis may have a lower chance of experiencing subjective cognitive decline compared to people who do not, according to a study published in the journal Current Alzheimer Research. Subjective cognitive decline (SCD) is a condition categorised by the self-reported experience of worsening or more frequent episodes of memory loss and confusion. It
Dancing the best exercise for treating depression, study says
A meta-analysis of over 200 studies has compared the effects of exercise on depression, and found that dancing produced the best outcomes. The study, published in the British Medical Journal, analysed the results of 218 unique studies to identify which kind of exercise best treats major depressive disorder, either alongside or instead of prescription antidepressants
Legalisation is not linked to an increase in cannabis-related psychosis
A study of data from pre and post-cannabis legalisation in Canada has found no increase in admissions to hospitals for cannabis-related episodes of psychosis. The relationship between cannabis use and episodes of psychosis is a contentious issue that is often raised by opponents of legalisation. Results from previous studies have been mixed, with some finding
Germany legalises personal possession of cannabis
The German parliament has voted in favour of legalising cannabis for personal use following a historic vote in the Bundestag today. Under the new legislation, which will come into force on April 1st 2024, cannabis will be removed from the official list of illegal substances that make up Germany’s narcotics law. Adults will be allowed
App launches feature to connect medical cannabis patients directly with doctors
A patient-facing app designed to offer an alternative to the cannabis clinic model prevalent in the UK has launched a new feature that can connect patients directly to doctors, according to a press release sent to leafie. Script Assist is a licensed online platform available via Apple and Android apps, as well as its website, which
Cannabis medicines “significantly improve sleep quality” insomnia study finds
Data derived from medical cannabis patients being treated for insomnia show that cannabis could be an effective treatment for the disorder that affects the sleep of approximately 10% of people living in the UK. The study, published in the journal Brain and Behavior, assessed clinical outcomes that were self-reported by patients who were being prescribed
Psychedelic use may improve sexual function, study finds
The consumption of psychedelics such as magic mushrooms and LSD may help to improve sexual function months after use according to a study published in the medical journal Nature. To understand the relationship between psychedelic use and sex, researchers from the Centre for Psychedelic Research at Imperial College London analysed questionnaire responses from almost 300